Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Internet Telehealth for Pediatric Asthma Case Management (CHESS)

This study has been completed.
National Institutes of Health (NIH)
Information provided by (Responsible Party):
University of Wisconsin, Madison Identifier:
First received: September 13, 2005
Last updated: January 16, 2013
Last verified: January 2013
The original and primary aim of this study is to evaluate the effects of CHESS with Nurse Case Management on asthma control (symptom-free days), and adherence factors of children aged 4-12. The investigators have expanded the scope of the specific aims. The criteria for their expanded aim is to also interview low-income African-American caregivers to gain an understanding of how they conceptualize their child's asthma, and what they consider to be barriers or facilitators to managing their child's asthma. There is no change in the investigators' original aim.

Condition Intervention
Behavioral: CHESS Internet telehealth

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Internet Telehealth for Pediatric Asthma Case Management

Further study details as provided by University of Wisconsin, Madison:

Primary Outcome Measures:
  • Percentage Changed in Adherence Score [ Time Frame: Baseline compared to the mean of the combined 3, 6, 9, and 12 month scores ]
    A baseline number of participants less dropouts was gauged against the weighted average of the number of participants in study period. The percentage change in adherence from baseline through the study was measured and is reported below, together with confidence intervals.

  • Number of Symptom-free Days [ Time Frame: Baseline compared to the mean of the combined 3, 6, 9, and 12 month scores ]
    A comparison in the average number of days that a child goes without asthma symptoms between experimental and control groups are shown below.

Secondary Outcome Measures:
  • Improvement in Asthma Control [ Time Frame: Baseline compared to the mean of the combined 3, 6, 9, and 12 month scores ]
    A six item survey on a seven point Likert scale measuring daytime and nocturnal asthma symptoms, missed school days and rescue medication use in the previous seven days. Lower scores signal better asthma control.

Enrollment: 301
Study Start Date: May 2004
Study Completion Date: May 2009
Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: CHESS + Case Mgt
Case Management (with monthly support calls) and CHESS services were available for a 12 month intervention period. Support calls refer to check in calls by a nurse to the parents to see how the child is doing. CHESS services include access to a website with information on asthma management, discussion groups and a case manager. The website also include a management tool for asthma symptoms check in, and the case manager used the information entered to tailor the homepage to individual clients.
Behavioral: CHESS Internet telehealth
CHESS Internet telehealth
No Intervention: Control
Control-usual care. Usual care refers to the manner in which clients generally manage their asthma.


Ages Eligible for Study:   4 Years to 12 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Parents of children, aged 4-12 with moderate to severe asthma
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00214383

Sponsors and Collaborators
University of Wisconsin, Madison
National Institutes of Health (NIH)
Principal Investigator: David Gustafson, PhD University of Wisconsin, Madison
  More Information

Responsible Party: University of Wisconsin, Madison Identifier: NCT00214383     History of Changes
Other Study ID Numbers: 2002-163
5R01NR007889-02 ( US NIH Grant/Contract Award Number )
Study First Received: September 13, 2005
Results First Received: April 4, 2012
Last Updated: January 16, 2013

Keywords provided by University of Wisconsin, Madison:
pediatric asthma

Additional relevant MeSH terms:
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases processed this record on April 26, 2017